Monopar Therapeutics Inc
(MNPR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,586 | -8,402 | -10,516 | -9,103 | -6,305 |
| Other Working Capital | 489 | -1,354 | 1,646 | 318 | 444 |
| Other Operating Activity | 8,693 | 1,898 | 1,641 | 1,468 | 1,199 |
| Operating Cash Flow | $-6,404 | $-7,858 | $-7,229 | $-7,317 | $-4,662 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -14,338 | 4,928 | -4,919 | N/A | N/A |
| Investing Cash Flow | $-14,338 | $4,928 | $-4,919 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 122 |
| Common Stock Issued | 59,396 | 2,074 | 110 | 10,943 | 8,175 |
| Other Financing Activity | -104 | -47 | -77 | -63 | -116 |
| Financing Cash Flow | $59,292 | $2,027 | $33 | $10,880 | $8,182 |
| Exchange Rate Effect | 1 | -17 | -4 | 5 | 3 |
| Beginning Cash Position | 7,266 | 8,186 | 20,304 | 16,737 | 13,214 |
| End Cash Position | 45,816 | 7,266 | 8,186 | 20,304 | 16,737 |
| Net Cash Flow | $38,550 | $-920 | $-12,118 | $3,567 | $3,523 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,404 | -7,858 | -7,229 | -7,317 | -4,662 |
| Free Cash Flow | -6,404 | -7,858 | -7,229 | -7,317 | -4,662 |